Posts by Former NIMH Director Thomas Insel from 2011

Dr. Insel shares NIMH’s Top 10 Research Advances for 2011.

Dr. Insel discusses opportunities for treatment development.

Dr. Insel discusses the state of psychiatric research and development (R&D) in the public and private sectors

Dr. Insel discusses the complicated nature of research on the efficacy antidepressants.

Dr. Insel reflects on an exciting neuroscience conference where an increasing interest in neuropsychiatric disorders was evident.

Dr. Insel describes how precision medicine may put us on the path to better diagnosis and treatment of mental disorders.

For Veterans Day, Dr. Insel discusses meeting the mental health needs of those who have so honorably served our country.

Two papers published this week in Nature provide the first maps of the molecular development of the human brain. Mapping brain development by changes in gene expression gives us a new level of precision and raises new possibilities for understanding the mechanisms of neurodevelopmental disorders.

Dr. Insel’s tour to Australia, Singapore, China and Japan reveal heavy investments in science and science education, indicating the time is ripe for collaboration.

Dr. Insel discusses World Mental Health Day and a new approach to meeting the shortage of mental health providers.

Results of the two largest studies of their kind, to date, have identified new common gene variants associated with schizophrenia and bipolar disorder. The results implicate specific pathways and hold promise for development of new treatments.

World Economic Forum report projects staggering costs of non-communicable diseases including mental health.

Dr. Insel discusses the implications of comorbidity among people with serious mental illness.

Dr. Insel discusses achieving diversity in the NIMH workforce and grantee population in light of a report in Science today.

Research on neural circuits is changing how mental illnesses are understood and may ultimately lead to new ways to treat brain disorders early enough to prevent symptoms.

Dr. Insel gives an update in our efforts to reduce suicide in America.

Global commonalities represent an opportunity for us to learn from the experiences in other countries or among other cultures to help improve mental health care in the U.S.

New studies published this Spring provide new insights into the molecular basis of autism, involving the interplay of genetic risk and environmental exposure.

Dr. Insel on investing in research.

A solver of “mysteries” — Howard Nash, M.D., Ph.D.

Dr. Insel discusses the promising future of psychiatry as it integrates new approaches discovered through neuroscience.

Dr. Insel provides a vision for future clinical research.

An emerging research technology using Induced pluripotent stem cells holds promise as a window into the developing brain in mental illness.

NIMH research can have a significant impact on public health through innovations and projects that cross the four objectives outlined in NIMH’s Strategic Plan.

Today, the start of Autism Awareness Month, inspires us to focus on the highlights of our research progress, and look ahead to further strengthening our investigative efforts.

Windows to completely new areas of research have been opened recently by research efforts in basic science. These reports force us to consider factors that have not previously been thought to have any role in mental health or illness.

The first transcription (genetic expression) map of the brain was recently posted. This is a landmark for brain research.

Dr. Insel discusses the impact of difficult budget times on mental health research.

As we mark the 10th anniversary of the human genome’s sequencing, the heightening pace of progress promises to a bright future for psychiatric genetics.

With the charge to become vanguards for the next generation of scientists, NIMH recognized the 12 recipients of the 2010 Biobehavioral Research Awards for Innovative New Scientists—or BRAINS.

Rapid progress in understanding how memory works – from the molecular to the behavioral level – holds promise for improved treatment of memory components of mental disorders.

Dr. Insel discuss what NIMH is doing to support economic research in light of mental health parity and health care reform.

When a tragedy occurs like the shooting in Tucson this past weekend, we are reminded of the urgent need for early diagnosis and treatment of people who may suffer from a serious mental illness.

Dr Insel discusses research priorities for 2011.